Tag: LUPIN

HOME » LUPIN » Page 3
» 2018-02-08

Pharma major Lupin said it has launched a generic version of Concordia’s ADHD drug Kapway in the US. Kapvay tablets has annual sales of approximately USD 66 million in the […]

» 2018-01-19

Pharma company Lupin said it has launched a generic version of Pfizer Inc.’s antibiotic Vibra-Tab. The drug has annual sales of around $144 million in the US, the Indian company […]

» 2017-12-28

Pharma Major Lupin announced that it has received final approval from the US Food & Drug Administration to market a generic version of Dovonex Scalp Solution from Leo Pharmaceutical Products […]

» 2017-12-14

Pharma Major Lupin said it got the approval of the US Food and Drug Administration to launch a generic version of Bayer’s oral contraceptive Safyral. The branded version has annual […]

» 2017-11-07

Pharma major Lupin said it a warning letter from the US Food and Drug Administration for its formulations manufacturing facilities in Goa and Indore on Monday. “We are deeply disappointed […]

» 2017-10-30

Pharma major Lupin reported an 8% fall in Q2 revenue to Rs. 3,952 cr. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) for the quarter fell by 13% to 927 […]

» 2017-10-26

Pharma Major Lupin said it received final approval from the United States Food and Drug Administration (FDA) to market a generic version of Concordia Pharmaceuticals Inc.’s ADHD drug Kapvay. It […]

» 2017-10-11

Pharma major Lupin said that its US subsidiary, Lupin, Inc has acquired Symbiomix Therapeutics, LLC for a cash consideration of USD 150 million including a USD 50 million upfront and […]

» 2017-10-09

Pharma manufacturer Lupin said it received approval to launch the generic version of US World Meds’ Corgard heart drug. Nadolol Tablets USP, 20 mg, 40 mg, and 80 mg Tablets […]

» 2017-09-13

Lupin said it received final approval to market a generic version of G.D. Searle LLC Flagyl antibiotic tablets in the US. Flagyl tablets had US sales of USD 44.1 million […]

» 2017-09-11

Pharma company Lupin said it received final approval from the US Food and Drug Administration for launching a generic version of Pfizer Inc.’s acne drug Vibra-Tabs. Doxycycline Hyclate Tablet 100 […]

» 2017-08-09

Pharmaceuticals company Lupin said it received a 505 (b)(2) NDA approval for its Nikita”M (Pitavastatin) Tablets 1 mg, 2 mg and 4 mg from the United States Food and Drug […]

» 2017-07-05

Pharma company Lupin said it launched Moxifloxacin Hydrochloride eye solution in the US. Lupin’s Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharms […]

» 2017-06-22

Pharma Major Lupin said it launched Desoximetasone cream for treating skin problems in the US market. The company had received approvals from the US Food and Drug Administration earlier. The […]

» 2017-06-15

India’s second biggest pharmaceutical company Lupin said it has launched the generic version of Valeant’s Wellbutrin antidepressant tablet Wellbutrin XL in the US. Wellbutrin XL tablet has yearly US sales […]

» 2017-06-14

Pharma Major Lupin said received final approval for launching a generic version of Mallinckrodt Inc.’s Roxicodone Tablets in the United States. The drug is used for the management of pain […]

» 2016-11-11

Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India. Lupin acquired the exclusive rights to market, distribute and […]

» 2016-10-06

Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products. Lupin would develop the pediatric products […]

» 2016-09-06

Pharma Major Lupin Limited (Lupin) announced that it received tentative approval from the United States Food and Drug Administration (FDA) for selling Silodosin capsules, a generic version of Allergan Sales’ […]

» 2016-09-01

Pharma Major Lupin Limited announced that its US subsidiary, Gavis Pharmaceuticals LLC., received tentative approval for selling a generic version of Pfizer Inc.’s Zithromax oral suspension from the US FDA. […]